CytoMed Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GDTC and other ETFs, options, and stocks.About GDTC
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments.
CEOWee Kiat Tan, PhD
CEOWee Kiat Tan, PhD
Employees43
Employees43
HeadquartersSingapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded2018
Founded2018
Employees43
Employees43
GDTC Key Statistics
Market cap15.25M
Market cap15.25M
Price-Earnings ratio-5.45
Price-Earnings ratio-5.45
Dividend yield—
Dividend yield—
Average volume22.23K
Average volume22.23K
High today$1.42
High today$1.42
Low today$1.26
Low today$1.26
Open price$1.42
Open price$1.42
Volume20.33K
Volume20.33K
52 Week high$3.68
52 Week high$3.68
52 Week low$1.26
52 Week low$1.26
Stock Snapshot
As of today, CytoMed Therapeutics(GDTC) shares are valued at $1.31. The company's market cap stands at 15.25M, with a P/E ratio of -5.45.
On 2026-01-09, CytoMed Therapeutics(GDTC) stock traded between a low of $1.26 and a high of $1.42. Shares are currently priced at $1.31, which is +3.9% above the low and -7.7% below the high.
CytoMed Therapeutics(GDTC) shares are trading with a volume of 20.33K, against a daily average of 22.23K.
In the last year, CytoMed Therapeutics(GDTC) shares hit a 52-week high of $3.68 and a 52-week low of $1.26.
In the last year, CytoMed Therapeutics(GDTC) shares hit a 52-week high of $3.68 and a 52-week low of $1.26.
People also own
Based on the portfolios of people who own GDTC. This list is generated using Robinhood data, and it’s not a recommendation.